Patents by Inventor Eric Allgaier

Eric Allgaier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230277636
    Abstract: Compositions include highly concentrated Alpha-1 Proteinase Inhibitor (A1PI) in a concentration greater than or equal to 100 mg/ml. Pharmaceutical compositions can be prepared from these compositions. The pharmaceutical compositions can be suitable for subcutaneous administration. The highly concentrated A1PI solutions can be obtained by single-pass tangential flow filtration (SPTFF).
    Type: Application
    Filed: May 12, 2023
    Publication date: September 7, 2023
    Inventors: James REBBEOR, Charles MILLER, Anthony KLOS, Eric ALLGAIER, Thomas P. ZIMMERMAN, Kevin WEE, Michelle StPETER, Kelly GLANCY
  • Patent number: 11701412
    Abstract: Compositions include highly-concentrated Alpha-1 Proteinase Inhibitor (A1PI) in a concentration greater than or equal to 100 mg/ml. Pharmaceutical compositions can be prepared from these compositions. The pharmaceutical compositions can be suitable for subcutaneous administration. The highly-concentrated A1PI solutions can be obtained by single-pass tangential flow filtration (SPTFF).
    Type: Grant
    Filed: September 22, 2021
    Date of Patent: July 18, 2023
    Assignee: GRIFOLS WORLDWIDE OPERATIONS LIMITED
    Inventors: James Rebbeor, Charles Miller, Anthony Klos, Eric Allgaier, Thomas P. Zimmerman, Kevin Wee, Michelle StPeter, Kelly Glancy
  • Patent number: 11253578
    Abstract: Compositions include highly-concentrated Alpha-1 Proteinase Inhibitor (A1PI) in a concentration greater than or equal to 100 mg/ml. Pharmaceutical compositions can be prepared from these compositions. The pharmaceutical compositions can be suitable for subcutaneous administration. The highly-concentrated A1PI solutions can be obtained by single-pass tangential flow filtration (SPTFF).
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: February 22, 2022
    Assignee: GRIFOLS WORLDWIDE OPERATIONS LIMITED
    Inventors: James Rebbeor, Charles Miller, Anthony Klos, Eric Allgaier, Thomas P. Zimmerman, Kevin Wee, Michelle StPeter, Kelly Glancy
  • Publication number: 20220000992
    Abstract: Compositions include highly-concentrated Alpha-1 Proteinase Inhibitor (A1PI) in a concentration greater than or equal to 100 mg/ml. Pharmaceutical compositions can be prepared from these compositions. The pharmaceutical compositions can be suitable for subcutaneous administration. The highly-concentrated A1PI solutions can be obtained by single-pass tangential flow filtration (SPTFF).
    Type: Application
    Filed: September 22, 2021
    Publication date: January 6, 2022
    Inventors: JAMES REBBEOR, CHARLES MILLER, ANTHONY KLOS, ERIC ALLGAIER, THOMAS P. ZIMMERMAN, KEVIN WEE, MICHELLE StPETER, KELLY GLANCY
  • Publication number: 20200038494
    Abstract: Compositions include highly-concentrated Alpha-1 Proteinase Inhibitor (A1PI) in a concentration greater than or equal to 100 mg/ml. Pharmaceutical compositions can be prepared from these compositions. The pharmaceutical compositions can be suitable for subcutaneous administration. The highly-concentrated A1PI solutions can be obtained by single-pass tangential flow filtration (SPTFF).
    Type: Application
    Filed: August 1, 2019
    Publication date: February 6, 2020
    Inventors: JAMES REBBEOR, CHARLES MILLER, ANTHONY KLOS, ERIC ALLGAIER, THOMAS P. ZIMMERMAN, KEVIN WEE, MICHELLE StPETER, KELLY GLANCY
  • Patent number: 10259969
    Abstract: A composition for use as an assay reagent includes a paramagnetic solid support comprising a coating of a synthetic copolymer. The synthetic copolymer comprises two or three of a first copolymerized monomer, a second copolymerized monomer and a third copolymerized monomer and further comprises a polyethylenic backbone.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: April 16, 2019
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Bhalchandra S. Lele, Eric Allgaier, Robert Pervere, Jeremy Lyons, Steve St-Onge
  • Publication number: 20180362796
    Abstract: A composition for use as an assay reagent includes a paramagnetic solid support comprising a coating of a synthetic copolymer. The synthetic copolymer comprises two or three of a first copolymerized monomer, a second copolymerized monomer and a third copolymerized monomer and further comprises a polyethylenic backbone.
    Type: Application
    Filed: August 23, 2018
    Publication date: December 20, 2018
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Bhalchandra S. Lele, Eric Allgaier, Robert Pervere, Jeremy Lyons, Steve St-Onge
  • Patent number: 10077376
    Abstract: A composition for use as an assay reagent includes a paramagnetic solid support comprising a coating of a synthetic copolymer. The synthetic copolymer comprises two or three of a first copolymerized monomer, a second copolymerized monomer and a third copolymerized monomer and further comprises a polyethylenic backbone.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: September 18, 2018
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Bhalchandra S. Lele, Eric Allgaier, Robert Pervere, Jeremy Lyons, Steve St-Onge
  • Publication number: 20160340541
    Abstract: A composition for use as an assay reagent includes a paramagnetic solid support comprising a coating of a synthetic copolymer. The synthetic copolymer comprises two or three of a first copolymerized monomer, a second copolymerized monomer and a third copolymerized monomer and further comprises a polyethylenic backbone.
    Type: Application
    Filed: January 29, 2015
    Publication date: November 24, 2016
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: Bhalchandra S. Lele, Eric Allgaier, Robert Pervere, Jeremy Lyons, Steve St-Onge